Mural Oncology PLC
MURA1.850USD
-0.470-20.26%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
1.870USD+1.870After-hours (ET)
31.94MMarket Cap
LossP/E TTM
Mural Oncology PLC
1.850
-0.470-20.26%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q1
FY2022Q4
FY2022Q3
Operating cash flows (indirect method)
Cash flow from continuing operating activities
1.45%-36.80M
25.64%-31.77M
40.41%-30.08M
---29.36M
33.01%-37.34M
-12.77%-42.73M
-35.31%-50.47M
---55.74M
---37.89M
---37.30M
Net income from continuing operations
-7.18%-33.14M
42.43%-34.27M
38.07%-31.76M
---31.56M
33.46%-30.92M
-22.55%-59.54M
-1.26%-51.28M
---46.47M
---48.58M
---50.64M
Operating gains losses
0.59%851.00K
41.60%868.00K
15.40%899.00K
--899.00K
59.62%846.00K
23.34%613.00K
109.41%779.00K
--530.00K
--497.00K
--372.00K
Other non-cash items
---96.00K
--287.00K
---592.00K
---2.37M
----
----
----
----
----
----
Change in working capital
47.93%-4.93M
-38.82%591.00K
111.65%344.00K
--2.48M
24.59%-9.47M
-86.20%966.00K
-131.10%-2.95M
---12.55M
--7.00M
--9.49M
-Change in receivables
-100.11%-4.00K
--1.34M
---388.00K
--890.00K
--3.65M
----
----
--0.00
----
----
-Change in prepaid expenses
69.99%-1.53M
-172.44%-1.53M
1297.56%573.00K
---1.48M
-596.97%-5.09M
661.01%2.11M
-90.42%41.00K
--1.02M
--277.00K
--428.00K
-Change in payables and accrued expense
56.83%-3.42M
139.39%1.16M
105.57%151.00K
--4.18M
45.95%-7.93M
-156.20%-2.96M
-128.60%-2.71M
---14.66M
--5.26M
--9.48M
-Change in other current assets
-7.89%1.31M
-71.62%994.00K
15.56%1.40M
--1.30M
-42.87%1.42M
19.07%3.50M
11.16%1.22M
--2.48M
--2.94M
--1.09M
-Change in other current liabilities
---45.00K
164.84%142.00K
494.29%138.00K
--0.00
-100.00%0.00
-7200.00%-219.00K
-75.00%-35.00K
--63.00K
---3.00K
---20.00K
Cash from non-recurring investing activities
Cash from operating activities
1.45%-36.80M
25.64%-31.77M
40.41%-30.08M
---29.36M
33.01%-37.34M
-12.77%-42.73M
-35.31%-50.47M
---55.74M
---37.89M
---37.30M
Investing cash flow
Net cash from continuing investing activities
-81.82%10.00K
-103.74%-44.00K
-98.80%14.00K
--0.00
-86.18%55.00K
723.78%1.18M
-56.75%1.17M
--398.00K
--143.00K
--2.70M
Capital expenditures
-81.82%10.00K
-98.05%23.00K
-98.80%14.00K
--0.00
-86.18%55.00K
723.78%1.18M
-56.75%1.17M
--398.00K
--143.00K
--2.70M
Net cash flow from disposal of fixed assets
-81.82%10.00K
-103.74%-44.00K
-98.80%14.00K
--0.00
-86.18%55.00K
723.78%1.18M
-56.75%1.17M
--398.00K
--143.00K
--2.70M
Net cash flow from investment products
122.49%28.00M
--36.17M
--19.33M
--43.68M
---124.48M
----
----
----
----
----
Cash from non-current investing activities
Net cash flow from investing activities
122.47%27.99M
3174.19%36.21M
1756.35%19.31M
--43.68M
-31191.46%-124.54M
-723.78%-1.18M
56.75%-1.17M
---398.00K
---143.00K
---2.70M
Financing cash flow
Cash flow from continuous financing activities
--28.00K
-100.00%0.00
-99.62%196.00K
--0.00
-100.00%0.00
728.35%315.01M
29.11%51.64M
--56.13M
--38.03M
--39.99M
Net cash flow from common stock issuance/repurchase
--28.00K
--0.00
--196.00K
----
----
----
----
----
----
----
Net cash flow from other financing activities
----
----
----
--0.00
-100.00%0.00
728.35%315.01M
29.11%51.64M
--56.13M
--38.03M
--39.99M
Net cash from non-recurrent financing activities
Net cash from financing activities
--28.00K
-100.00%0.00
-99.62%196.00K
--0.00
-100.00%0.00
728.35%315.01M
29.11%51.64M
--56.13M
--38.03M
--39.99M
Net cash flow
Beginning cash balance
-56.69%117.43M
--112.99M
--123.56M
--109.23M
--271.11M
--0.00
--0.00
--0.00
--0.00
--0.00
Current period cash flow changes
94.58%-8.78M
-98.36%4.44M
---10.57M
--14.32M
---161.88M
--271.11M
--0.00
--0.00
--0.00
--0.00
Ending cash balance
-0.53%108.65M
-56.69%117.43M
--112.99M
--123.56M
--109.23M
--271.11M
--0.00
--0.00
--0.00
--0.00
Free cash flow
1.56%-36.81M
27.58%-31.79M
41.72%-30.09M
---29.36M
33.39%-37.39M
-15.45%-43.90M
-29.11%-51.64M
---56.13M
---38.03M
---39.99M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
